- By FYH News Team
- Published on
The “Evolving Landscape for Diverse Clinical Trials: Legislation, Community & Stakeholders” topic was originally presented at the 2022 National Minority Quality Forum Annual Leadership Summit on Health Disparities and Health Braintrust. Listen now for a closer look at addressing existing disparities.
Panelists:
Mark Fleury, PhD, Policy Principal, American Cancer Society Cancer Action Network (ACS-CAN)
Lloryn Hubbard, Associate Director, Lead-Patient Diversity Clinical Research PPD, part of Thermo Fisher Scientific
Salvatore (Salvo) Alesci, MD, PhD, Chief Scientist & Strategy Officer, Beyond Celiac
Maha Radhakrishnan, MD Group, Senior Vice President & Chief Medical Officer, Biogen
Dora Hughes, MD, MPH, Chief Medical Officer, The CMS Innovation Center at the Centers for Medicare and Medicaid Services
Christina Edwards, MHA Clinical Trials Director National Minority Quality Forum (Moderator)
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
